Diurnal rhythm of cholesterol biosynthesis in experimental chronic renal failure

被引:9
作者
Chmielewski, M
Nieweglowski, T
Swierczynski, J
Rutkowski, B
Boguslawski, W
机构
[1] Med Univ Gdansk, Dept Chem, PL-80211 Gdansk, Poland
[2] Med Univ Gdansk, Dept Nephrol, PL-80211 Gdansk, Poland
[3] Med Univ Gdansk, Dept Biochem, PL-80211 Gdansk, Poland
关键词
cholesterol biosynthesis; hypercholesterolemia; chronic renal failure; mevalonate; HMG-CoA reductase;
D O I
10.1023/A:1013395921241
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Changes in lipid metabolism are an important risk factor for vascular complications during chronic renal failure (CRF). In experimental CRF hypercholesterolemia has been found to be the main lipid disorder. It is probably due to enhanced cholesterologenesis. Mechanisms of these changes remain poorly understood. It is well known that activity of cholesterologenesis undergoes a significant diurnal rhythm. However, there was no evidence that this rhythm is still present in the course of experimental CRF. Results of our studies indicate that in contrast to puromycin induced nephrotic syndrome, diurnal rhythm of cholesterologenesis in CRF rats is preserved both in liver and in the intestine tissue. Significant higher incorporation of tritiated water into cholesterol fraction was found in vivo both in liver as well as in intestine of CRF rats, as compared to control animals. Increased (with comparison to the controls) incorporation of C-14-acetate, and H-3-mevalonate into CRF rat liver sterols indicate that mechanism of enhanced cholesterologenesis is more complex than simply due to the elevated level of mevalonate (potential substrate for cholesterologenesis) which has been reported in plasma of CRF animals.
引用
收藏
页码:33 / 37
页数:5
相关论文
共 19 条
[1]   Lipoprotein abnormalities as a risk factor for progressive nondiabetic renal disease [J].
Attman, PO ;
Alaupovic, P ;
Samuelsson, O .
KIDNEY INTERNATIONAL, 1999, 56 :S14-S17
[2]   MODULATION OF THE ENZYMATIC-ACTIVITY OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE BY MULTIPLE KINASE SYSTEMS INVOLVING REVERSIBLE PHOSPHORYLATION - A REVIEW [J].
BEG, ZH ;
STONIK, JA ;
BREWER, HB .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1987, 36 (09) :900-917
[3]   Genesis of atherosclerosis in uremic patients [J].
Drüeke, TB .
MINERAL AND ELECTROLYTE METABOLISM, 1999, 25 (4-6) :251-257
[4]   Evaluation of serum lipid abnormalities in chronic nephritis [J].
Hirano, H ;
Yamada, Y ;
Otani, H ;
Kodama, N ;
Mune, M ;
Yukawa, S .
KIDNEY INTERNATIONAL, 1999, 56 :S147-S149
[5]   PHARMACOLOGIC TREATMENT OF HYPERLIPIDEMIA REDUCES GLOMERULAR INJURY IN RAT 5/6 NEPHRECTOMY MODEL OF CHRONIC RENAL-FAILURE [J].
KASISKE, BL ;
ODONNELL, MP ;
GARVIS, WJ ;
KEANE, WF .
CIRCULATION RESEARCH, 1988, 62 (02) :367-374
[6]   Gene expression of LDL, receptor, HMG-CoA reductase, and cholesterol-7 alpha-hydroxylase in chronic renal failure [J].
Liang, K ;
Vaziri, ND .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1997, 12 (07) :1381-1386
[7]   DOWN-REGULATION OF ATRIAL-NATRIURETIC-FACTOR CLEARANCE RECEPTORS IN EXPERIMENTAL CHRONIC-RENAL-FAILURE RATS [J].
LUK, JKH ;
WONG, EFC ;
WONG, NLM .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1995, 269 (03) :H902-H908
[8]   The diurnal variation of hepatic HMG-CoA reductase activity is due to changes in the level of immunoreactive protein [J].
Ness, GC ;
Chambers, GM .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1996, 327 (01) :41-44
[9]   LOVASTATIN BUT NOT ENALAPRIL REDUCES GLOMERULAR INJURY IN DAHL SALT-SENSITIVE RATS [J].
ODONNELL, MP ;
KASISKE, BL ;
KATZ, SA ;
SCHMITZ, PG ;
KEANE, WF .
HYPERTENSION, 1992, 20 (05) :651-658
[10]   POSTTRANSCRIPTIONAL REGULATION OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME-A REDUCTASE AND CHOLESTEROL 7-ALPHA-HYDROXYLASE IN RATS WITH SUBTOTAL NEPHRECTOMY [J].
PANDAK, WM ;
VLAHCEVIC, ZR ;
HEUMAN, DM ;
KRIEG, RJ ;
HANNA, JD ;
CHAN, JCM .
KIDNEY INTERNATIONAL, 1994, 46 (02) :358-364